This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glick, A. B. Articles by Yuspa, S. H. Search for Related Content PubMed PubMed Citation Articles by Glick, A. B. Articles by Yuspa, S. H.

Transforming Growth Factor ß1 Suppresses Genomic Instability Independent of a G₁ Arrest, p53, and Rb

Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Basic Science, National Cancer Institute, Bethesda, Maryland 20892

Alterations in expression of or responsiveness to transforming growth factor ß (TGF-ß) are frequently found in human and animal epithelial cancers and are thought to be important for loss of growth control in the neoplastic cell. We show here that keratinocyte cell lines from mice with a targeted deletion of the TGF-ß1 gene have significantly increased frequencies of gene amplification in response to the drug N-phosphonoacetyl-L-aspartate (PALA) compared to TGF-ß1-expressing control keratinocyte cell lines. In contrast to the control lines, the PALA-mediated G₁ arrest did not occur in the TGF-ß1 null keratinocytes despite the presence of wild-type p53 in both genotypes. Exogenous TGF-ß1 suppresses gene amplification in the null keratinocytes at concentrations that do not cause a G₁ growth arrest and in human tumor cell lines that are insensitive to TGF-ß1-mediated growth inhibition. The pathway of TGF-ß1 suppression is independent of the p53 and Rb genes, but requires an intact TGF-ß type II receptor. These studies reveal a novel TGF-ß-mediated pathway regulating genomic stability and suggest that defects in TGF-ß signaling may have profound effects on tumor progression independent of cell proliferation.

¹ To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Basic Science, National Cancer Institute, Building 37, Room 3B-25, 37 Convent Drive MSC 4255, Bethesda, MD 20892. Phone: (301) 496-3248; Fax: (301) 496-8709.

Received 5/13/96. Accepted 6/28/96.

This article has been cited by other articles:

				J. C McCann and B. N Ames Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am. J. Clinical Nutrition, October 1, 2009; 90(4): 889 - 907. [Abstract] [Full Text] [PDF]

				C. A. Maxwell, M. C. Fleisch, S. V. Costes, A. C. Erickson, A. Boissiere, R. Gupta, S. A. Ravani, B. Parvin, and M. H. Barcellos-Hoff Targeted and Nontargeted Effects of Ionizing Radiation That Impact Genomic Instability Cancer Res., October 15, 2008; 68(20): 8304 - 8311. [Abstract] [Full Text] [PDF]

				J. Kirshner, M. F. Jobling, M. J. Pajares, S. A. Ravani, A. B. Glick, M. J. Lavin, S. Koslov, Y. Shiloh, and M. H. Barcellos-Hoff Inhibition of Transforming Growth Factor-{beta}1 Signaling Attenuates Ataxia Telangiectasia Mutated Activity in Response to Genotoxic Stress Cancer Res., November 15, 2006; 66(22): 10861 - 10869. [Abstract] [Full Text] [PDF]

				M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400. [Abstract] [Full Text] [PDF]

				E. Forrester, A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A.-R. Sharif-Afshar, W. J. Muller, and H. L. Moses Effect of Conditional Knockout of the Type II TGF-{beta} Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis Cancer Res., March 15, 2005; 65(6): 2296 - 2302. [Abstract] [Full Text] [PDF]

				R. S. Muraoka-Cook, N. Dumont, and C. L. Arteaga Dual Role of Transforming Growth Factor ss in Mammary Tumorigenesis and Metastatic Progression Clin. Cancer Res., January 15, 2005; 11(2): 937s - 943s. [Abstract] [Full Text] [PDF]

				M H Barcellos-Hoff How tissues respond to damage at the cellular level: orchestration by transforming growth factor-{beta} (TGF-{beta}) Br. J. Radiol., January 1, 2005; Supplement_27(1): 123 - 127. [Abstract] [Full Text] [PDF]

				R. S. Muraoka-Cook, H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga Conditional Overexpression of Active Transforming Growth Factor {beta}1 In vivo Accelerates Metastases of Transgenic Mammary Tumors Cancer Res., December 15, 2004; 64(24): 9002 - 9011. [Abstract] [Full Text] [PDF]

				S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]

				P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis Cancer Res., September 15, 2004; 64(18): 6524 - 6529. [Abstract] [Full Text] [PDF]

				A. B. Roberts and L. M. Wakefield The two faces of transforming growth factor {beta} in carcinogenesis PNAS, July 22, 2003; 100(15): 8621 - 8623. [Full Text] [PDF]

				R. Bommireddy, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, and T. Doetschman TGF{beta}1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes J. Immunol., April 1, 2003; 170(7): 3645 - 3652. [Abstract] [Full Text] [PDF]

				K. B. Ewan, R. L. Henshall-Powell, S. A. Ravani, M. J. Pajares, C. Arteaga, R. Warters, R. J. Akhurst, and M. H. Barcellos-Hoff Transforming Growth Factor-{beta}1 Mediates Cellular Response to DNA Damage in Situ Cancer Res., October 15, 2002; 62(20): 5627 - 5631. [Abstract] [Full Text] [PDF]

				D. M. Shin, N. Charuruks, S. M. Lippman, J. J. Lee, J. Y. Ro, W. K. Hong, and W. N. Hittelman p53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 603 - 609. [Abstract] [Full Text] [PDF]

				A. Glick, N. Popescu, V. Alexander, H. Ueno, E. Bottinger, and S. H. Yuspa Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes PNAS, December 21, 1999; 96(26): 14949 - 14954. [Abstract] [Full Text] [PDF]

				B. Tang, K. de Castro, H. E. Barnes, W. T. Parks, L. Stewart, E. P. Bottinger, D. Danielpour, and L. M. Wakefield Loss of Responsiveness to Transforming Growth Factor {beta} Induces Malignant Transformation of Nontumorigenic Rat Prostate Epithelial Cells Cancer Res., October 1, 1999; 59(19): 4834 - 4842. [Abstract] [Full Text] [PDF]

				H. Yamada, K. Vijayachandra, C. Penner, and A. Glick Increased Sensitivity of Transforming Growth Factor (TGF) beta 1 Null Cells to Alkylating Agents Reveals a Novel Link between TGFbeta Signaling and O6-Methylguanine Methyltransferase Promoter Hypermethylation J. Biol. Chem., May 25, 2001; 276(22): 19052 - 19058. [Abstract] [Full Text] [PDF]